Announced Thu, 21 Aug · 18:45 IST

Appointment of Secretarial Auditor.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Pharmaids Pharmaceuticals has appointed CS Kashinath Sahu (of M/s Kashinath Sahu & Co, Practicing Company Secretaries) as its Secretarial Auditor for a period of five consecutive financial years, from FY2025-26 to FY2029-30. The appointment was approved by the Board on August 21, 2025, based on the recommendation of the Audit Committee, and is subject to shareholder approval at the upcoming Annual General Meeting. CS Kashinath Sahu has over 35 years of experience, including 24 years in full-time practice handling secretarial audits, compliance, mergers, due diligence, and SEBI/listing matters for listed companies. The appointment is a routine regulatory requirement under SEBI's Listing Regulations.

Likely market impact

This is a routine governance and compliance appointment and is unlikely to have any direct impact on the stock price or shareholder value. It reflects adherence to SEBI disclosure norms and continuity in secretarial audit oversight.